Analysis of Geographic Areas
Allergan Inc. operates in 5 regions: United States; Europe; Latin America; Asia Pacific; and Other.
Area Asset Turnover
Allergan Inc., asset turnover by geographic area
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 1.01 | 0.90 | 0.94 | 0.92 | 0.94 |
| Europe | 2.25 | 2.17 | 2.08 | 2.16 | 1.65 |
| Latin America | 7.73 | 7.34 | 7.18 | 6.58 | 4.98 |
| Asia Pacific | 10.83 | 9.06 | 8.34 | 7.67 | 5.93 |
| Other | 158.42 | 195.14 | 118.59 | 85.54 | 57.70 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2012 to 2013 but then improved from 2013 to 2014 exceeding 2012 level. |
| Europe | Europe area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. | |
| Latin America | Latin America area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. | |
| Asia Pacific | Asia Pacific area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. | |
| Other | Other area asset turnover ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. |
Area Asset Turnover: United States
Allergan Inc.; United States; area asset turnover calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Product net sales | 4,520,500) | 3,839,400) | 3,478,400) | 3,221,600) | 3,017,000) |
| Long-lived assets | 4,497,000) | 4,274,700) | 3,718,600) | 3,500,900) | 3,222,400) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 1.01 | 0.90 | 0.94 | 0.92 | 0.94 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area asset turnover = Product net sales ÷ Long-lived assets
= 4,520,500 ÷ 4,497,000 = 1.01
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2012 to 2013 but then improved from 2013 to 2014 exceeding 2012 level. |
Area Asset Turnover: Europe
Allergan Inc.; Europe; area asset turnover calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Product net sales | 1,410,300) | 1,237,800) | 1,121,400) | 1,086,600) | 931,600) |
| Long-lived assets | 627,100) | 569,900) | 538,600) | 502,000) | 563,100) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.25 | 2.17 | 2.08 | 2.16 | 1.65 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area asset turnover = Product net sales ÷ Long-lived assets
= 1,410,300 ÷ 627,100 = 2.25
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Europe | Europe area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. |
Area Asset Turnover: Latin America
Allergan Inc.; Latin America; area asset turnover calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Product net sales | 382,000) | 383,000) | 399,200) | 390,700) | 323,700) |
| Long-lived assets | 49,400) | 52,200) | 55,600) | 59,400) | 65,000) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 7.73 | 7.34 | 7.18 | 6.58 | 4.98 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area asset turnover = Product net sales ÷ Long-lived assets
= 382,000 ÷ 49,400 = 7.73
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Latin America | Latin America area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. |
Area Asset Turnover: Asia Pacific
Allergan Inc.; Asia Pacific; area asset turnover calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Product net sales | 512,300) | 464,100) | 448,900) | 408,700) | 333,800) |
| Long-lived assets | 47,300) | 51,200) | 53,800) | 53,300) | 56,300) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 10.83 | 9.06 | 8.34 | 7.67 | 5.93 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area asset turnover = Product net sales ÷ Long-lived assets
= 512,300 ÷ 47,300 = 10.83
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Asia Pacific | Asia Pacific area asset turnover ratio improved from 2012 to 2013 and from 2013 to 2014. |
Area Asset Turnover: Other
Allergan Inc.; Other; area asset turnover calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Product net sales | 301,000) | 273,200) | 260,900) | 239,500) | 213,500) |
| Long-lived assets | 1,900) | 1,400) | 2,200) | 2,800) | 3,700) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 158.42 | 195.14 | 118.59 | 85.54 | 57.70 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area asset turnover = Product net sales ÷ Long-lived assets
= 301,000 ÷ 1,900 = 158.42
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Other | Other area asset turnover ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. |
Area Capital Expenditures to Depreciation
Allergan Inc., capital expenditures to depreciation by geographic area
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 0.53 | 0.45 | 0.39 | 0.34 | 0.31 |
| Europe | 2.81 | 1.61 | 1.24 | 0.92 | 0.70 |
| Latin America | 0.97 | 0.99 | 0.71 | 0.67 | 0.81 |
| Asia Pacific | 0.46 | 0.46 | 0.43 | 0.47 | 1.03 |
| Other | 0.00 | 0.00 | 0.13 | 0.00 | 0.13 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | United States | United States area capital expenditures to depreciation ratio improved from 2012 to 2013 and from 2013 to 2014. |
| Europe | Europe area capital expenditures to depreciation ratio improved from 2012 to 2013 and from 2013 to 2014. | |
| Latin America | Latin America area capital expenditures to depreciation ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. | |
| Asia Pacific | Asia Pacific area capital expenditures to depreciation ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. | |
| Other |
Area Capital Expenditures to Depreciation: United States
Allergan Inc.; United States; area capital expenditures to depreciation calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Capital expenditures | 98,400) | 82,300) | 75,700) | 63,600) | 62,800) |
| Depreciation and amortization | 187,300) | 181,200) | 194,700) | 187,900) | 202,200) |
| Area Financial Ratio | |||||
| Area capital expenditures to depreciation1 | 0.53 | 0.45 | 0.39 | 0.34 | 0.31 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 98,400 ÷ 187,300 = 0.53
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | United States | United States area capital expenditures to depreciation ratio improved from 2012 to 2013 and from 2013 to 2014. |
Area Capital Expenditures to Depreciation: Europe
Allergan Inc.; Europe; area capital expenditures to depreciation calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Capital expenditures | 136,400) | 79,700) | 59,500) | 46,300) | 29,300) |
| Depreciation and amortization | 48,500) | 49,600) | 48,100) | 50,300) | 42,000) |
| Area Financial Ratio | |||||
| Area capital expenditures to depreciation1 | 2.81 | 1.61 | 1.24 | 0.92 | 0.70 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 136,400 ÷ 48,500 = 2.81
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | Europe | Europe area capital expenditures to depreciation ratio improved from 2012 to 2013 and from 2013 to 2014. |
Area Capital Expenditures to Depreciation: Latin America
Allergan Inc.; Latin America; area capital expenditures to depreciation calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Capital expenditures | 6,900) | 7,600) | 6,000) | 6,600) | 6,700) |
| Depreciation and amortization | 7,100) | 7,700) | 8,400) | 9,800) | 8,300) |
| Area Financial Ratio | |||||
| Area capital expenditures to depreciation1 | 0.97 | 0.99 | 0.71 | 0.67 | 0.81 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 6,900 ÷ 7,100 = 0.97
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | Latin America | Latin America area capital expenditures to depreciation ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. |
Area Capital Expenditures to Depreciation: Asia Pacific
Allergan Inc.; Asia Pacific; area capital expenditures to depreciation calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Capital expenditures | 2,200) | 2,300) | 2,000) | 2,100) | 3,900) |
| Depreciation and amortization | 4,800) | 5,000) | 4,600) | 4,500) | 3,800) |
| Area Financial Ratio | |||||
| Area capital expenditures to depreciation1 | 0.46 | 0.46 | 0.43 | 0.47 | 1.03 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 2,200 ÷ 4,800 = 0.46
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | Asia Pacific | Asia Pacific area capital expenditures to depreciation ratio improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014. |
Area Capital Expenditures to Depreciation: Other
Allergan Inc.; Other; area capital expenditures to depreciation calculation
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Capital expenditures | —) | —) | 100) | —) | 100) |
| Depreciation and amortization | 400) | 600) | 800) | 900) | 800) |
| Area Financial Ratio | |||||
| Area capital expenditures to depreciation1 | 0.00 | 0.00 | 0.13 | 0.00 | 0.13 |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 2014 Calculation
Area capital expenditures to depreciation = Capital expenditures ÷ Depreciation and amortization
= 0 ÷ 400 = 0.00
| Area financial ratio | Geographic area | The company |
|---|---|---|
| Area capital expenditures to depreciation | Other |
Product net sales
Allergan Inc., product net sales by geographic area
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 4,520,500) | 3,839,400) | 3,478,400) | 3,221,600) | 3,017,000) |
| Europe | 1,410,300) | 1,237,800) | 1,121,400) | 1,086,600) | 931,600) |
| Latin America | 382,000) | 383,000) | 399,200) | 390,700) | 323,700) |
| Asia Pacific | 512,300) | 464,100) | 448,900) | 408,700) | 333,800) |
| Other | 301,000) | 273,200) | 260,900) | 239,500) | 213,500) |
| Total | 7,126,100) | 6,197,500) | 5,708,800) | 5,347,100) | 4,819,600) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
Long-lived assets
Allergan Inc., long-lived assets by geographic area
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 4,497,000) | 4,274,700) | 3,718,600) | 3,500,900) | 3,222,400) |
| Europe | 627,100) | 569,900) | 538,600) | 502,000) | 563,100) |
| Latin America | 49,400) | 52,200) | 55,600) | 59,400) | 65,000) |
| Asia Pacific | 47,300) | 51,200) | 53,800) | 53,300) | 56,300) |
| Other | 1,900) | 1,400) | 2,200) | 2,800) | 3,700) |
| Total | 5,222,700) | 4,949,400) | 4,368,800) | 4,118,400) | 3,910,500) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
Depreciation and amortization
Allergan Inc., depreciation and amortization by geographic area
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 187,300) | 181,200) | 194,700) | 187,900) | 202,200) |
| Europe | 48,500) | 49,600) | 48,100) | 50,300) | 42,000) |
| Latin America | 7,100) | 7,700) | 8,400) | 9,800) | 8,300) |
| Asia Pacific | 4,800) | 5,000) | 4,600) | 4,500) | 3,800) |
| Other | 400) | 600) | 800) | 900) | 800) |
| Total | 248,100) | 244,100) | 256,600) | 253,400) | 257,100) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
Capital expenditures
Allergan Inc., capital expenditures by geographic area
US$ in thousands
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
|---|---|---|---|---|---|
| United States | 98,400) | 82,300) | 75,700) | 63,600) | 62,800) |
| Europe | 136,400) | 79,700) | 59,500) | 46,300) | 29,300) |
| Latin America | 6,900) | 7,600) | 6,000) | 6,600) | 6,700) |
| Asia Pacific | 2,200) | 2,300) | 2,000) | 2,100) | 3,900) |
| Other | —) | —) | 100) | —) | 100) |
| Total | 243,900) | 171,900) | 143,300) | 118,600) | 102,800) |
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).